Merck Buys Peloton Therapeutics in $2.2 Billion Deal

Life Science

Mabpharm Hong Kong IPO to Raise $172 Million at $900 Million Valuation

Life Science

Exuma Reports Positive Early Results from China Trial of Conditionally Active Biologics

Life Science

HempWave Acquires Two Arizona Greenhouses with over 210,000 Square Feet of Growing Space to Supply Industrial Hemp Seeds and Clones

Cannabis, Life Science

Cannabis Growth Opportunity Corporation Announces NAV of $3.41

Cannabis, Life Science

Trump administration postpones some Medicare drug-cost proposals

Life Science

New Mountain Capital Completes $3.8 Billion Initial Public Offering of Avantor

Life Science

Hangzhou’s AnHeart Completes $14.6 Million A Funding from Decheng

Life Science

ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings

Life Science

LGC Capital Announces Agreement to Acquire a Significant Interest in Fully Licenced European Pharmaceutical Company, Freia Farmaceutici Srl.

Cannabis, Life Science

Amazon’s online drug push has one start-up cutting staff and selling pharmacies to help businesses compete

Life Science

Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

Life Science

WuXi Biologics Starts Building Chengdu Manufacturing Plant, its 12th Globally

Life Science

Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

Life Science

Alphabet’s Verily and GV are getting behind an ambitious new venture called Verve Therapeutics.

Life Science